Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors Fluidx Medical’s GPX Embolic Device was used to effectively devascularize a large tumor with multiple feeding vessels as part of a multi-center clinical trial. “This could have been a challenging case since it involved a large renal tumor fed by small, low flow, […]
Read MoreOne of the items featured on PIVOT Center’s new website is a video including several important partners in the Utah innovation ecosystem discussing the role of the U and the PIVOT Center in the state’s innovation economy. The short film highlights the uniqueness of Utah’s collaborative environment, especially PIVOT Center serving as a “Catalyst for […]
Read MoreAt CES 2022, Gentex displays multiple technologies focused on driver and cabin monitoring as well as new convenience features that will help automakers sell cars. Gentex acquired Vaporsens (a University of Utah Start up) in April 2020 and is using that company’s nanofiber chemical-sensing technology in a sensor that can be installed in a vehicle’s […]
Read MoreSalarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other cancers, today announced a definitive agreement with DeuteRx, LLC to acquire an oral, small molecule targeted protein degradation portfolio. The acquisition includes a lead drug candidate that Salarius has renamed SP-3164 (formerly DRX-164), the related patent family, including […]
Read MoreUTAH’S PREMIER EVENT FOR INVESTMENT IN THE LIFE SCIENCES INDUSTRY We’ll be back in person for the 2022 BioHive Entrepreneur & Investor Life Sciences Summit. Join us at the Summit to hear industry experts speak on compelling topics such as funding, operating and developing life sciences companies on March 9-10, 2021. Don’t miss this chance […]
Read MoreSALT LAKE CITY – The University of Utah last week released its 2021 Innovation Report, detailing how the university has a seemingly golden touch when it comes to startup companies. A precedent-setting $884 million in investments was raised by U. startups in 2021 and technologies developed by University of Utah faculty and students contributed to […]
Read MoreIn publishing the FY21 Innovation Report the University of Utah’s (the U) PIVOT Center highlights several important partnerships, including Recursion and RenalytixAI. The report also celebrates some of the U’s innovation by promoting quantitative and qualitative metrics, such as the precedent-setting $884 million in investments raised by U startup companies; and technologies developed by University of […]
Read MoreUniversity of Utah start up Recursion Pharmaceuticals created an on-site center for its headquarters in Salt Lake City, Utah. It launched in July. Heather Kirkby, chief people officer at Recursion, says it was a resource their CEO Chris Gibson wanted all the employees to have when he founded the company in 2015. Read the Full […]
Read MoreCarterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has signed an exclusive Asia-Pacific and Oceania region distribution agreement with PerkinElmer, Inc. a global leader committed to innovating for a healthier world. With the agreement, PerkinElmer will market, sell, and service Carterra’s flagship LSA high-throughput surface plasmon resonance (SPR) platform and […]
Read MoreSALT LAKE CITY, UT — Following Elute, Inc.’s Investigational Device Exemption (IDE) authorization from the US Food and Drug Administration (FDA) to use its EP Granules with Tobramycin(TM) in a pivotal clinical trial, the Hospital for Special Surgery (HSS), and the Rothman Orthopaedic Institute (Rothman) have agreed to become clinical sites to evaluate the safety and […]
Read More